Delivery Order SPE2DB20D1004-SPE2DB25FNGKA

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,822.38 firm fixed-price delivery order is for the supply of NAFTIN 2% GEL 60GM, a topical antifungal medication. The contract has an ultimate completion date of April 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,057.46 firm-fixed-price contract is for the delivery of Naftifine HCL 2% gel, a topical antifungal medication, with a completion date of April 25, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,129.11 firm fixed-price delivery order is for the supply of NAFTIFINE HCL 2% GEL 60GM, a topical antifungal medication. The contract has a period of performance through February 28, 2025 and is not associated with any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naftifine HCL 2% gel, a topical antifungal medication. The delivery order has a ceiling value of $2,819.69 and is a firm-fixed price contract. The ultimate completion date for this order is May 12, 2025. This award is not set aside and represents an open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $10,960.98, is for the delivery of NAFTIN 1% GEL 40GM, a pharmaceutical product, with a completion date of November 28, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,477.36, is for the delivery of 4560955312 NAFTIN 1% GEL 40GM, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through May 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,406.94 firm-fixed-price delivery order is for the supply of NAFTIN 1% GEL 60GM, a pharmaceutical product. The contract has an ultimate completion date of September 6, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This is a $1,282.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NAFTIN 1% GEL 60GM, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of January 23, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the supply of NAFTIN 2% Gel, a prescription pharmaceutical product, with a ceiling value of $2,583.70. The contract is a Delivery Order with a firm fixed-price pricing structure and an ultimate completion date of August 12, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract to provide the specified medication to support the healthcare needs of military...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,125.43 Firm Fixed Price delivery order contract is for the supply of Naftifine HCL 2% Gel, a pharmaceutical product. The contract has an ultimate completion date of December 30, 2024 and was awarded on December 27, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNGKA
    Delivery Order

This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,576.67 firm-fixed-price contract is for the supply of Naftin 2% gel, a topical antifungal medication. The contract has an ultimate completion date of April 17, 2025.

AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC allows the company to supply a wide range of pharmaceutical products and medical supplies to support military and government healthcare programs.

The contract award is not designated as a set-aside, indicating open competition. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp is a critical vendor in supporting the federal government's medical procurement needs, particularly for the military and veteran healthcare systems.

Generated 7/16/25, 12:15 PM